Literature DB >> 10485305

Metabolic stroke in isolated 3-methylcrotonyl-CoA carboxylase deficiency.

C Steen1, E R Baumgartner, M Duran, W Lehnert, T Suormala, R Fingerhut, M Stehn, A Kohlschütter.   

Abstract

A mildly retarded infant with failure to thrive developed hypoglycaemia, focal seizures, respiratory failure and hemiparesis during a febrile episode at the age of 16 months. A brain scan was initially normal and showed hemilateral focal edema and gliosis at later stages. 3-Methylcrotonyl-CoA carboxylase deficiency was suggested by elevated urinary excretion of 3-hydroxyisovaleric acid and 3-methylcrotonylglycine, and confirmed by enzyme assays. The patient was treated with protein restriction and carnitine and remained stable during the following 5 years. Hemiparesis and some developmental delay persisted. In acute focal brain disease, metabolic disorders must be considered. 3-Methylcrotonyl-CoA carboxylase deficiency adds to the list of possible causes of "metabolic stroke".

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10485305     DOI: 10.1007/s004310051189

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  11 in total

1.  The molecular basis of human 3-methylcrotonyl-CoA carboxylase deficiency.

Authors:  M R Baumgartner; S Almashanu; T Suormala; C Obie; R N Cole; S Packman; E R Baumgartner; D Valle
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

Review 2.  The consequences of extended newborn screening programmes: do we know who needs treatment?

Authors:  B Wilcken
Journal:  J Inherit Metab Dis       Date:  2008-02-22       Impact factor: 4.982

3.  Isolated 3-methylcrotonyl-coenzyme A carboxylase deficiency in a child with metabolic stroke.

Authors:  L Pinto; P Zen; R Rosa; G Paskulin; A Perla; L Barea; M R Baumgartner; M F Dantas; B Fowler; R Giugliani; C Vargas; M Wajner; C Graziadio
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

4.  Leukodystrophy and CSF purine abnormalities associated with isolated 3-methylcrotonyl-CoA carboxylase deficiency.

Authors:  Raquel Dodelson de Kremer; Alexandra Latini; Terttu Suormala; E Regula Baumgartner; Laura Laróvere; Gabriel Civallero; Norberto Guelbert; Ana Paschini-Capra; Catalina Depetris-Boldini; Carlos Quiroga Mayor
Journal:  Metab Brain Dis       Date:  2002-03       Impact factor: 3.584

5.  Acute extrapyramidal syndrome in mild ornithine transcarbamylase deficiency: metabolic stroke involving the caudate and putamen without metabolic decompensation.

Authors:  C E Keegan; D M Martin; D J Quint; J L Gorski
Journal:  Eur J Pediatr       Date:  2003-02-07       Impact factor: 3.183

6.  Outcomes of cases with 3-methylcrotonyl-CoA carboxylase (3-MCC) deficiency - Report from the Inborn Errors of Metabolism Information System.

Authors:  RaeLynn Forsyth; Catherine Walsh Vockley; Mathew J Edick; Cynthia A Cameron; Sally J Hiner; Susan A Berry; Jerry Vockley; Georgianne L Arnold
Journal:  Mol Genet Metab       Date:  2016-02-15       Impact factor: 4.797

7.  3-methylcrotonyl-CoA carboxylase deficiency: clinical, biochemical, enzymatic and molecular studies in 88 individuals.

Authors:  Sarah C Grünert; Martin Stucki; Raphael J Morscher; Terttu Suormala; Celine Bürer; Patricie Burda; Ernst Christensen; Can Ficicioglu; Jürgen Herwig; Stefan Kölker; Dorothea Möslinger; Elisabetta Pasquini; René Santer; K Otfried Schwab; Bridget Wilcken; Brian Fowler; Wyatt W Yue; Matthias R Baumgartner
Journal:  Orphanet J Rare Dis       Date:  2012-05-29       Impact factor: 4.123

8.  Consanguinity and rare mutations outside of MCCC genes underlie nonspecific phenotypes of MCCD.

Authors:  Peter J Shepard; Bruce A Barshop; Matthias R Baumgartner; John-Bjarne Hansen; Kristen Jepsen; Erin N Smith; Kelly A Frazer
Journal:  Genet Med       Date:  2014-11-06       Impact factor: 8.822

9.  Brain magnetic resonance imaging and proton MR spectroscopic findings after metabolic crisis in 3-methylcrotonylglycinuria.

Authors:  Ghazi Adlan Alshumrani; Zoltan Patay
Journal:  Ann Saudi Med       Date:  2015 Jan-Feb       Impact factor: 1.526

10.  Defective mitochondrial rRNA methyltransferase MRM2 causes MELAS-like clinical syndrome.

Authors:  Caterina Garone; Aaron R D'Souza; Cristina Dallabona; Tiziana Lodi; Pedro Rebelo-Guiomar; Joanna Rorbach; Maria Alice Donati; Elena Procopio; Martino Montomoli; Renzo Guerrini; Massimo Zeviani; Sarah E Calvo; Vamsi K Mootha; Salvatore DiMauro; Ileana Ferrero; Michal Minczuk
Journal:  Hum Mol Genet       Date:  2017-11-01       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.